Concepedia

Mariko Kita

MK

Statistics

Publications

24

Citations

2.5K

H-Index

19

Active since

1992

Affiliations

Virginia Mason Medical Center(Current)

Biogen (United States)

Cleveland Clinic

Charles University

St. Vincent's University Hospital

Mariko Kita is an author at Virginia Mason Medical Center specializing in multiple sclerosis, life sciences, and neuroimmunology.

Publications per year

1992–2023

24

Publications

24

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

, , +6

In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive T <sub>regs</sub> Involves IL-6–Mediated Signaling

Anya Schneider, S. Alice Long, Karen Cerosaletti et al. · Science Translational Medicine · 2013 · 153 citations

, , +17

Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients

Karen Cerosaletti, Anya Schneider, Katharine V. Schwedhelm et al. · PLoS ONE · 2013 · 120 citations · Full text

, , +17

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

, , +14

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Bruce Cree, Gary Cutter, Jerry S. Wolinsky et al. · The Lancet Neurology · 2020 · 104 citations · Full text

, , +9

1–5 of 24